RecallDepth
Class II Terminated

Buprenorphine HCl Injection, 0.3 mg/mL, 1 mL vial, For Intramuscular or Intravenous Use Only, Rx Only, Manufactured by: Hikma Farmaceutica, Portugal S.A., Distributed by: Hikma Pharmaceuticals, Eatontown, NJ 07724, USA Inc., NDC: 0143-9246-01.

Company
Hikma Pharmaceuticals Usa Inc.
Recall Initiated
August 14, 2020
Posted
September 2, 2020
Recall Number
D-1533-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
97,890 vials
Firm Location
Cherry Hill, NJ, United States

Reason for Recall

Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.

Distribution

Nationwide in the U.S.

Lot / Code Info

Lot #s: 2005023.1, 2005024.1, 2005025.1, Exp 02/28/2021

More recalls by Hikma Pharmaceuticals Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls